Limited coverage drugs – terbinafine

Last updated on October 17, 2022
Generic name terbinafine
Strength 250 mg
Form tablet

Criteria

Approval period

For the treatment of severe onychomycosis

PLUS

functional disability

PLUS

positive KOH or dermatophyte culture of nail from a licensed lab
 
First approval: Three months

Renewals: If required, up to three months.

Practitioner exemptions

  • None

Special notes

  • Terbinafine cream is not eligible for PharmaCare coverage.

Special Authority requests